MariMed Inc. Reports Q1 2025 Loss Amid Strategic Efforts to Expand in Cannabis Market
MariMed Inc. reported a loss for Q1 2025, falling short of revenue estimates, but CEO Jon Levine emphasized the company’s commitment to expanding its market presence and product offerings in the cannabis industry.
2 minutes to read